Marc Iskowitz

Marc Iskowitz

Marc Iskowitz has covered healthcare marketing, advertising and media for MM&M since 2005, but has followed the medical beat in a variety of roles since ‘96 or so. He has also moderated judging panels for the MM&M Awards. If you have story ideas, tips or criticism, e-mail me. And feel free to follow me on Twitter.

Most Recent Articles by Marc Iskowitz

Editor's Desk: Intrigues de Palais

Editor's Desk: Intrigues de Palais

Can agencies prove that regulations no longer hinder Grand Prix-level branded work?

Agency Intro: Not Your Father's Agency

Agency Intro: Not Your Father's Agency

Agency business again appears to be up for a healthy cross-section of companies this year. And, according to our annual business barometer of healthcare firms, the new agency is thriving on a diet of mostly digital work on both the HCP and consumer sides. Meanwhile, the increased emphasis on creating memorable content and patient-centered user experiences appears to be a driving force in pharmaceutical clients' marketing strategy. Marc Iskowitz reports

Agency Think Tank: Strong Performers

The emphasis on providing service and value in healthcare has prompted the industry's largest holding companies to fuse their capabilities as they seek to connect this industry's disparate stakeholders. As told to Marc Iskowitz

Myelin acquires agencies in Chicago and Atlanta

Fourth and fifth members of network add healthcare advertising and PR expertise.

Pioneering info portal for doctors turns 20

Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.

More Articles by Marc Iskowitz

Disruption on display

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.